Corcept Therapeutics Stock Price. Everything You Need To Know About The Corcept Therapeutics Stock!
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. The company is headquartered in Menlo Park, California and currently employs 299 full-time employees. The company went IPO on 2004-04-15. The firm operates through the discovery, development and commercialization of the pharmaceutical products segment. The firm has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, exicorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.
Corcept Therapeutics Stock Price. Everything You Need To Know About The Corcept Therapeutics Stock! performance
- Employees 299
- Company HQ Menlo Park
- Website https://www.corcept.com/
- CORT Asset Type Common Stock
- CORT Market Capitalization 2.6B
- Earnings Per Share 1.05
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0.786
Investing in the stock market can be a rewarding endeavor, but it’s important to make informed decisions. If you’re a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the healthcare sector, Corcept Therapeutics is a stock worth considering. Corcept Therapeutics specializes in the development and commercialization of drugs for severe metabolic and psychiatric disorders. With its promising pipeline and strong market presence, investing in Corcept Therapeutics can be a smart move. To invest in this stock, you can use the investment platform Zorion, which offers real US stock investments and pre-IPO opportunities. Zorion also provides investment insights, recommendations, and educational resources to help you make well-informed investment decisions. Start investing in Corcept Therapeutics today and position yourself for potential growth and success in the healthcare sector.
